Oxford and AstraZeneca announce their vaccine is 70% effective on average in preliminary results By Martin Robinson, Chief Reporter For Mailonline Published: 07:14 GMT, 23 November 2020 | Updated: 07:14 GMT, 23 November 2020 The Oxford University/AstraZeneca coronavirus vaccine is 70 per cent effective at preventing COVID-19, preliminary results have revealed. The life-saving jab is Britain’s … Read more
Encouraging the public to visit bars and restaurants and then closing hospitality due to a spike in Covid-19 cases is not a ‘sensible way to run the epidemic’, a Government scientific adviser has said. Professor John Edmunds, a member of the Scientific Advisory Group for Emergencies (Sage), urged a long-term strategy when it comes to … Read more
AstraZeneca did not turn over coronavirus vaccine trial safety data to the US Food and Drug Administration (FDA) for one month, a new report claims. The late-stage study, being conducted with Oxford University, was put on hold on September 9 when a British participant was rushed to the hospital after suffering a serious reaction that … Read more
AstraZeneca did not turn over coronavirus vaccine trial safety data to the US Food and Drug Administration (FDA) for one month, a new report claims. The late-stage study, being conducted with Oxford University, was put on hold on September 9 when a British participant was rushed to the hospital after suffering a serious reaction that … Read more
The Oxford coronavirus vaccine could still be ready by the end of this year or early next year, the company developing it has claimed, despite trials being paused this week. Pascal Soriot, the CEO of drug giant AstraZeneca, told an online event he thought vaccine development remained ‘on track’ but they would have to wait … Read more
The world may be one step closer to getting a coronavirus jab after Oxford University’s vaccine candidate entered its final stage of tests in the US. UK drug giant AstraZeneca, which owns the rights to the vaccine, said it had enrolled 30,000 American volunteers to take part in its phase three clinical trial. It now means … Read more
Pharmaceutical giant AstraZeneca is now injecting volunteers with its new antibody treatment for Covid-19 in a bid to see if it will protect people and also help patients who are already ill. The company, which is also manufacturing a vaccine hopeful made by scientists at Oxford University, hope the treatment will be a coronavirus breakthrough. … Read more
Pharmaceutical giant AstraZeneca has dismissed claims its experimental Covid-19 vaccine could be fast-tracked in the US amid reports Donald Trump wants to get it approved before the presidential election this autumn. White House insiders claim the US President is considering speeding up regulatory approval for the jab, originally developed by Oxford University scientists. Getting a … Read more
Astrazeneca signs deals to sell coronavirus vaccine to Argentina and Mexico By Matt Oliver For The Daily Mail Published: 21:50 BST, 13 August 2020 | Updated: 21:50 BST, 13 August 2020 Astrazeneca is forging ahead with its potential coronavirus vaccine after signing fresh supply deals in Latin America. Argentina and Mexico are the latest countries … Read more
AstraZeneca and Johnson & Johnson promised to offer their coronavirus vaccines to the US at cost during testimony before a Congressional committee on Tuesday. UK-based Astrazeneca also said that it would ramp up production of its prospective vaccine – created with Oxford University – to ensure that 300 million doses are available to the US … Read more